CUE-102 in Recurrent Glioblastoma
Clinical trial NCT06917885 · RECRUITING
Trial details
- NCT number
- NCT06917885
- Sponsor
- David Reardon, MD
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-30
- Primary completion
- 2027-01-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.